CorWave
France - ClichyBiotechnology
Focus: CorWave is a French biotechnology company specializing in blood pump technology for advanced heart failure, operating at mid-stage scale with 51-200 employees.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Employees
51-200
Open Jobs
7-3 this month
Stable — net -3 jobs in 30d
2 added, 5 removed. Backfill posture.
Should You Work at CorWave?
AI assessmentAttractive for manufacturing, regulatory, or early-stage development professionals willing to bet on a focused cardiovascular play with European upside, but proceed cautiously without transparency on funding and timeline.
Why Work Here
- Focused portfolio in high-unmet-need cardiovascular/rare disease space with single lead program (LVAS) reducing distraction and enabling deep expertise
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Growing
Jobs increasing
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
N/A
Clinical Trials (1)
NCT06907017CorWave LVAS FIH Study
N/AHelp build intelligence for CorWave
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.